About PeptiDream
PeptiDream is a publicly listed company based in Erimo (Japan) founded in 2006. Peptide-based drugs are developed for diverse medical indications. The company has 621 employees. Its website peptidream.com draws about 42 thousand monthly visits. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.
Company details
PeptiDream was founded in 2006 and is headquartered in Erimo, Japan. Operations focus on the biotechnology sector, where peptide-based therapeutics are created using the proprietary PDPS (Peptide Discovery Platform System) technology. Drug development targets areas including oncology, multiple myeloma, DMD and muscle disorders, influenza, and additional indications, with efforts centered on small molecule solutions for unmet medical needs.
- Headquarters Erimo, Japan
- Employees 621
- Stage Public
- SectorsHealthcare
- Website category Finance · Investing
- Website peptidream.com
- Social LinkedIn X YouTube
- Legal Name Peptidream Inc.
- Annual Revenue$118.21 M (USD)-60.32as on Dec 31, 2025
- Net Profit-$23.94 M (USD)-124.97as on Dec 31, 2025
- EBITDA-$18.19 M (USD)-112.05as on Dec 31, 2025
- InvestorsGates Foundation
& 1 more
- Employee Count621
Funding Insights of PeptiDream
- Total Rounds 3
- Investors Count 2
All 3 funding rounds of PeptiDream with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2019 | Grant | – | – | ||
| Nov 2017 | Grant | – | – | ||
| Jul 2008 | Series A | – | – |
2 investors in total: 2 institutional.
Investors in PeptiDream
PeptiDream has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation and UT-EC Japan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed and Early stage VC firm investing in Japan | ut-ec.co.jp | Tokyo, Japan | ||
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States |
Investor details for PeptiDream
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of PeptiDream
PeptiDream is a publicly listed company on the TSE with ticker symbol 4587 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date11 Jun 2013
- Listed onTSE: 4587
- Listed entityPeptidream Inc.
- Exchange sectorHealth technology
- ISINJP3836750004
- Share price1,041.50 JPY (-3.65% on the day) · 2026-10-14
- Market capitalisation140,341,943,344.00 JPY
- EPS (diluted, trailing year)-28.11 JPY
- Volume (last session)1,532,900
Financials of PeptiDream
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 18.52B JPY | -3.75B JPY | -2.85B JPY |
| 2024 | 46.68B JPY | 15.01B JPY | 23.64B JPY |
| 2023 | 28.71B JPY | 3.04B JPY | 9.61B JPY |
| 2022 | 26.85B JPY | 7.55B JPY | 11.32B JPY |
| 2021 | 9.42B JPY | 2.57B JPY | 4.68B JPY |
Detailed financial statements for PeptiDream
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of PeptiDream
4 dated milestones of PeptiDream across 13 years, from founding to its latest funding, stage changes and deals.
- Founded PeptiDream is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Grant,.
Web traffic of PeptiDream
The website of PeptiDream (peptidream.com) receives about 41.6K visits a month and ranks #741,291 among all websites worldwide, #7,144 in Investing.
- Monthly visits41.6K
▲ 9.4% vs previous month
- Unique visitors10.5K
per month
- Global rank#741,291
among all websites
- Category rank#7,144
Finance · Investing
- Bounce rate43%
- Pages per visit2.8
- Average visit2 min 07 sec
- DevicesDesktop 60% · Mobile 40%
Websites whose visitors overlap most with PeptiDream. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medrx.co.jp | 100% | 4.3K | #3,767,389 | View details | |
finance.yahoo.co.jp | finance.yahoo.co.jp | 94% | #530 | – | |
| fidelity.co.jp | 88% | #232,940 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Peptidream
Complete news archive for PeptiDream
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PeptiDream
PeptiDream was founded in 2006 and raised its 1st funding round 2 years after it was founded.
PeptiDream is headquartered in Erimo, Japan. It is registered at Erimo, Hokkaido, Japan.
PeptiDream has 621 employees.
Annual revenue of PeptiDream is $118.21M as on Dec 31, 2025.
PeptiDream was founded in 2006 and is headquartered in Erimo, Japan. Operations focus on the biotechnology sector, where peptide-based therapeutics are created using the proprietary PDPS (Peptide Discovery Platform System) technology. Drug development targets areas including oncology, multiple myeloma, DMD and muscle disorders, influenza, and additional indications, with efforts centered on small molecule solutions for unmet medical needs.
Yes, PeptiDream is publicly traded on TSE under the ticker symbol 4587.
PeptiDream has 2 investors. Key investors include Gates Foundation, and UT-EC Japan.